Insider Transactions in Q2 2023 at Bristol Myers Squibb CO (BMY)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2023
|
Adam Lenkowsky EVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
551
-51.16%
|
$35,815
$65.66 P/Share
|
|
Jun 03
2023
|
Adam Lenkowsky EVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,077
+50.0%
|
-
|
|
May 03
2023
|
Rupert Vessey EVP & President, Research |
SELL
Open market or private sale
|
Direct |
50,385
-51.34%
|
$3,375,795
$67.06 P/Share
|
|
May 02
2023
|
Sharon Greenlees SVP & Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-26.28%
|
$23,528
$68.1 P/Share
|
|
May 02
2023
|
Sharon Greenlees SVP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
1,017
+40.53%
|
-
|
|
May 02
2023
|
Sharon Greenlees SVP & Controller |
SELL
Other acquisition or disposition
|
Direct |
62
-9.0%
|
-
|
|
Apr 01
2023
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
SELL
Payment of exercise price or tax liability
|
Direct |
1,692
-34.4%
|
$116,748
$69.31 P/Share
|
|
Apr 01
2023
|
Karin Shanahan EVP, Glob. Prod. Dev. & Supply |
BUY
Exercise of conversion of derivative security
|
Direct |
3,306
+40.2%
|
-
|
|
Apr 01
2023
|
Elizabeth Mily EVP, Strategy & BD |
SELL
Payment of exercise price or tax liability
|
Direct |
3,198
-4.51%
|
$220,662
$69.31 P/Share
|
|
Apr 01
2023
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Exercise of conversion of derivative security
|
Direct |
6,346
+8.33%
|
-
|
|
Apr 01
2023
|
Elizabeth Mily EVP, Strategy & BD |
BUY
Other acquisition or disposition
|
Direct |
1,190
+3.27%
|
-
|